State attorneys general yesterday announced a $26 billion proposed settlement with Johnson & Johnson and distributors McKesson, Cardinal Health and Amerisource Bergen over the companies’ alleged role in creating and fueling the opioid epidemic. A number of states have signed the agreement, which still must be signed by other state and local governments involved in the litigation. They said most of the settlement would go to opioid treatment and prevention, with each state’s share based on a formula that takes into account factors such as the number of overdose deaths, opioids prescribed and residents with substance use disorder.

Related News Articles

Headline
In this AHA Advancing Health podcast, Marie Cleary-Fishman, vice president of clinical quality for the AHA Center for Health Innovation, and Holly Geyer, M.D…
Chairperson's File
The opioid epidemic has been an incredibly challenging public health crisis in communities across our country. And it’s clear the COVID-19 pandemic has…
Headline
AHA member organizations are undertaking a variety of efforts to address opioid issues in their communities. Hear examples of some of those efforts from Alicia…
Headline
Although COVID-19 has been a significant contributor to the substance abuse epidemic, it does not explain the large number of drug overdose deaths between May…
#HealthCareInnovation Thursday Blog
If there has ever been a time for opioid stewardship, it’s now. Between May 2019 and May 2020, the United States had the highest number of drug overdose…
Headline
The Department of Health and Human Services today released new practice guidelines for administering buprenorphine, which exempt from certain training and…